| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 02/14/2002 | CA2412368A1 Benzimidazole derivatives, preparation and therapeutic use thereof |
| 02/14/2002 | CA2411928A1 Pyrazole-thiazole compounds, pharmaceutical compositions containing them, and methods of their use for inhibiting cyclindependent kinases |
| 02/14/2002 | CA2406961A1 Cd40 antagonists for use in treating psoriasis and other inflammatory skin conditions |
| 02/14/2002 | CA2386103A1 Vascular endothelial growth factor 2 |
| 02/13/2002 | EP1179338A1 Cosmetic and dermatological compositions comprising cyclodextrines for removing sebum |
| 02/13/2002 | EP1179334A2 Hair tonic for preventing or treating hair loss |
| 02/13/2002 | EP1179065A2 Full-length molecules expressed in human tissues |
| 02/13/2002 | EP1179064A2 Secreted polypeptides and corresponding polynucleotides |
| 02/13/2002 | EP1179052A2 Serine proteases |
| 02/13/2002 | EP1179005A1 Steroid compounds with a c17-alkyl side chain and an aromatic a-ring for use in therapy |
| 02/13/2002 | EP1178984A2 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives |
| 02/13/2002 | EP1178983A1 Indole-type derivatives as inhibitors of p38 kinase |
| 02/13/2002 | EP1178981A1 Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylactic methods |
| 02/13/2002 | EP1178977A1 Ion channel modulating agents |
| 02/13/2002 | EP1178963A1 Ion channel modulating agents |
| 02/13/2002 | EP1178962A1 Process for the preparation of paroxetine acetate and analogues thereof |
| 02/13/2002 | EP1178960A1 Vitamin d analogues and their pharmaceutical use |
| 02/13/2002 | EP1178959A1 Alpha-amino-beta-sulfonyl hydroxamic acid compounds |
| 02/13/2002 | EP1178958A2 N-cyanomethyl amides as protease inhibitors |
| 02/13/2002 | EP1178952A1 NOVEL INTERLEUKIN-1 AND TUMOR NECROSIS FACTOR-$g(a) MODULATORS, SYNTHESES OF SAID MODULATORS AND METHODS OF USING SAID MODULATORS |
| 02/13/2002 | EP1178834A1 Controlled release of growth factors from heparin containing matrices |
| 02/13/2002 | EP1178818A1 A stable composition comprising epidermal growth factor as an active ingredient |
| 02/13/2002 | EP1178816A2 Materials for soft tissue augmentation and methods of making and using same |
| 02/13/2002 | EP1178812A2 Conditioned cell culture medium compositions and methods of use |
| 02/13/2002 | EP1178808A1 Pharmaceutical composition |
| 02/13/2002 | EP1178801A2 Combination of nicotinic acid or nicotinamide with riboflavin for the treatment of pruritus, itching and inflammation disorders |
| 02/13/2002 | EP1178799A1 Microgranules insoluble in gastric fluid, method for obtaining same and pharmaceutical preparations |
| 02/13/2002 | EP1178776A1 Methods of regulating the condition of mammalian keratinous tissue |
| 02/13/2002 | EP1178736A1 A composition containing carvacrol and thymol for use as a bactericide |
| 02/13/2002 | EP0737199B1 Method for preparing concentrated biologically active silicon compounds |
| 02/13/2002 | CN1335881A UME extract having medicinal effects and compositions containing the same |
| 02/13/2002 | CN1335853A Alpha v beta b integrin inhibitors |
| 02/13/2002 | CN1335849A Pyrrolopyrimidines as protein kinase inhibitors |
| 02/13/2002 | CN1335841A N-(iminomethyl) amine derivatives, their preparation, their use as medicines and compositions containing them |
| 02/13/2002 | CN1335838A Pyrimidine compounds |
| 02/13/2002 | CN1335836A Tricyclic pyrazole derivatives |
| 02/13/2002 | CN1335774A Soya extract containing lipids, process for its production, and pharmaceutical and cosmetic composition |
| 02/13/2002 | CN1335771A N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 02/13/2002 | CN1335764A Substrate composition and method of use for sequestration of skin irritants |
| 02/13/2002 | CN1335763A Skin care compositions containing cis-9, trans-11 linoleic acid |
| 02/13/2002 | CN1335757A Hemostatic polymer useful for rapid blood coagulation and hemostasis |
| 02/13/2002 | CN1335309A New eka-favone and its application in preparation of cosmetic and dermatology |
| 02/13/2002 | CN1335179A Leukoderma treating oral medicine powder and external liniment |
| 02/13/2002 | CN1335171A Gynopathy treating Chinese medicine with functions of diminishing inflammation and eliminating spot and its prepn |
| 02/13/2002 | CN1335164A Leukoderma treating medicine and its prepn |
| 02/13/2002 | CN1335160A Burns treating ointment with functions of removing necrosis and promoting granulation |
| 02/13/2002 | CN1335135A Artificial skin powder prepn containing sodium hyaluronate and its prepn |
| 02/13/2002 | CN1335123A Acne-eliminating beautifying sunset abelmoschus liquid and its prepn |
| 02/12/2002 | US6346626 Drugs for treatment of skin disorders such as acne, seborrhea, androgenic alopecia and hirsutism, or in the topical treatment of squamous cell carcinoma |
| 02/12/2002 | US6346608 MecB |
| 02/12/2002 | US6346546 Biaromatic compounds and pharmaceutical and cosmetic compositions comprising them |
| 02/12/2002 | US6346541 Antitumor and anticarcinogenic agents for breast, lung, and skin cancer |
| 02/12/2002 | US6346539 Treatment of skin conditions |
| 02/12/2002 | US6346537 Medicinal composition |
| 02/12/2002 | US6346520 Antitumor and anticarcinogenic agents; psoriasis |
| 02/12/2002 | US6346398 Ribozyme or antisense nucleic acid which inhibits synthesis, gene expression and/or stability of messenger rna encoding the flt-1 receptor of human or mouse receptor; treatment of diabetic retinopathy; angiogenesis inhibitors |
| 02/12/2002 | US6346251 Antiproliferation agents for skin disorders |
| 02/12/2002 | US6346247 Prevention and treatment of autoimmune disease with luminally administered polyclonal antibodies |
| 02/12/2002 | CA2073453C Methods of enhancing wound healing and tissue repair |
| 02/12/2002 | CA2031817C Use of thrombospondin to promote wound healing |
| 02/12/2002 | CA2006891C Composition to induce and stimulate the growth of hair and/or slow down their shedding, based on pyrimidine derivatives and sun screens |
| 02/07/2002 | WO2002010406A2 Metalloproteinase-disintegrin polypeptides and methods of making and use thereof |
| 02/07/2002 | WO2002010405A2 A human disintegrin protein |
| 02/07/2002 | WO2002010388A2 C3b/C4b COMPLEMENT RECEPTOR-LIKE MOLECULES AND USES THEREOF |
| 02/07/2002 | WO2002010387A2 G-protein coupled receptors |
| 02/07/2002 | WO2002010371A1 Novel physiologically active peptide and use thereof |
| 02/07/2002 | WO2002010363A2 Protein phosphatases |
| 02/07/2002 | WO2002010347A2 Directed differentiation of embryonic cells |
| 02/07/2002 | WO2002010261A1 Soybean-based thermoplastics as biomaterials |
| 02/07/2002 | WO2002010217A2 Endothelial cell expression patterns |
| 02/07/2002 | WO2002010216A2 Proteins and nucleic acids encoding same |
| 02/07/2002 | WO2002010199A2 C3b/c4b complement receptor-like molecules and uses thereof |
| 02/07/2002 | WO2002010172A1 Azabicyclic compounds, preparation thereof and use as medicines, in particular as antibacterial agents |
| 02/07/2002 | WO2002010168A1 Novel guanidino derivatives as inhibitors of cell adhesion |
| 02/07/2002 | WO2002010164A2 Dihydronaphthyridine- and dihydropyrrolopyridine-derivated compounds as potassium channel openers |
| 02/07/2002 | WO2002010162A1 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl] carboxamide inhibitors of cyclin dependent kinases |
| 02/07/2002 | WO2002010161A1 Process for preparing arylacetylaminothiazoles |
| 02/07/2002 | WO2002010158A2 3-indolyl-4-phenyl-1h-pyrrole-2,5-dione derivatives as inhibitors of glycogen synthase kinase-3beta |
| 02/07/2002 | WO2002010148A1 Novel coumarin derivatives and the salts thereof, a process for the preparation thereof and their use in the pharmaceutical field |
| 02/07/2002 | WO2002010143A1 Non-steroidal inflammation inhibitors |
| 02/07/2002 | WO2002010141A1 Imidazole derivatives |
| 02/07/2002 | WO2002010140A2 Imidazolyl derivatives |
| 02/07/2002 | WO2002010139A1 Hexahydro-7-1h-azepin-2-yl-haxanoic acid derivatives as inhibitors of inducible nitric oxide synthase |
| 02/07/2002 | WO2002010137A2 Indazole derivatives as jnk inhibitors |
| 02/07/2002 | WO2002010136A1 3-substituted isoquinolin-1-yl derivatives |
| 02/07/2002 | WO2002010135A1 3,4-dihydroisoquinoline derivative compounds and drugs containing these compounds as the active ingredient |
| 02/07/2002 | WO2002010120A1 Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy |
| 02/07/2002 | WO2002009768A2 Therapeutic polyesters and polyamides |
| 02/07/2002 | WO2002009765A1 Methods for treating burns on mammalian skin to reduce the risk of infection and to minimize fluid loss |
| 02/07/2002 | WO2002009729A2 Treatment of hyperproliferative skin disorders and diseases |
| 02/07/2002 | WO2002009701A1 Use of selective adenosine a1 receptor agonists, antagonists and allosteric enhancers to manipulate angiogenesis |
| 02/07/2002 | WO2002009690A2 Pharmaceutical composition comprising a photochemotherapeutic agent and a mucoadhesive agent |
| 02/07/2002 | WO2002009687A1 Use of n-oleoylethanolamine for treating psoriasis |
| 02/07/2002 | WO2002009686A2 Cdc25 phosphatase inhibitors |
| 02/07/2002 | WO2002009676A1 Adhesive dressings for the treatment and prophylaxis of scars |
| 02/07/2002 | WO2002009639A2 Methods and pharmaceutical compositions for healing wounds |
| 02/07/2002 | WO2001081310A8 1-aroyl-piperidinyl benzamidines |
| 02/07/2002 | WO2001080813A3 Methods for preventing and treating alopecia induced by chemotherapy or radiotherapy |
| 02/07/2002 | WO2001074811A3 Substituted 1,3-thiazole compounds, their production and use |
| 02/07/2002 | WO2001066101A3 Treatment of psoriasis |